Nature. 2022 Apr;604(7907):749-756. doi: 10.1038/s41586-022-04638-9. Epub 2022 Apr 20.
Au-Yeung G, et al.CCNE1 Amplification as a Therapeutic Target .J Clin Oncol.2023 Feb 2;JCO2202267.doi: 10.1200/JCO.22.02267. Online ahead of print.
Fu S,et al.Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification.J Clin Oncol. 2022 Dec 5;JCO2200830. doi: 10.1200/JCO.22.00830. Online ahead of print.